Importance: Single-center and claims-based studies have described substantial changes in the landscape of care in the cardiac intensive care unit (CICU). Professional societies have recommended research to guide evidence-based CICU redesigns. Objective: To characterize patients admitted to contemporary, advanced CICUs. Design, Setting, and Participants: This study established the Critical Care Cardiology Trials Network (CCCTN), an investigator-initiated multicenter network of 16 advanced, tertiary CICUs in the United States and Canada. For 2 months in each CICU, data for consecutive admissions were submitted to the central data coordinating center (TIMI Study Group). The data were collected and analyzed between September 2017 and 2018. Main Outcomes and Measures: Demographics, diagnoses, management, and outcomes. Results: Of 3049 participants, 1132 (37.1%) were women, 797 (31.4%) were individuals of color, and the median age was 65 years (25th and 75th percentiles, 55-75 years). Between September 2017 and September 2018, 3310 admissions were included, among which 2557 (77.3%) were for primary cardiac problems, 337 (10.2%) for postprocedural care, 253 (7.7%) for mixed general and cardiac problems, and 163 (4.9%) for overflow from general medical ICUs. When restricted to the initial 2 months of medical CICU admissions for each site, the primary analysis population included 3049 admissions with a high burden of noncardiovascular comorbidities. The top 2 CICU admission diagnoses were acute coronary syndrome (969 [31.8%]) and heart failure (567 [18.6%]); however, the proportion of acute coronary syndrome was highly variable across centers (15%-57%). The primary indications for CICU care included respiratory insufficiency (814 [26.7%]), shock (643 [21.1%]), unstable arrhythmia (521 [17.1%]), and cardiac arrest (265 [8.7%]). Advanced CICU therapies or monitoring were required for 1776 patients (58.2%), including intravenous vasoactive medications (1105 [36.2%]), invasive hemodynamic monitoring (938 [30.8%]), and mechanical ventilation (652 [21.4%]). The overall CICU mortality rate was 8.3% (95% CI, 7.3%-9.3%). The CICU indications that were associated with the highest mortality rates were cardiac arrest (101 [38.1%]), cardiogenic shock (140 [30.6%]), and the need for renal replacement therapy (51 [34.5%]). Notably, patients admitted solely for postprocedural observation or frequent monitoring had a mortality rate of 0.2% to 0.4%. Conclusions and Relevance: In a contemporary network of tertiary care CICUs, respiratory failure and shock predominated indications for admission and carried a poor prognosis. While patterns of practice varied considerably between centers, a substantial, low-risk population was identified. Multicenter collaborative networks, such as the CCCTN, could be used to help redesign cardiac critical care and to test new therapeutic strategies.
Importance: Single-center and claims-based studies have described substantial changes in the landscape of care in the cardiac intensive care unit (CICU). Professional societies have recommended research to guide evidence-based CICU redesigns. Objective: To characterize patients admitted to contemporary, advanced CICUs. Design, Setting, and Participants: This study established the Critical Care Cardiology Trials Network (CCCTN), an investigator-initiated multicenter network of 16 advanced, tertiary CICUs in the United States and Canada. For 2 months in each CICU, data for consecutive admissions were submitted to the central data coordinating center (TIMI Study Group). The data were collected and analyzed between September 2017 and 2018. Main Outcomes and Measures: Demographics, diagnoses, management, and outcomes. Results: Of 3049 participants, 1132 (37.1%) were women, 797 (31.4%) were individuals of color, and the median age was 65 years (25th and 75th percentiles, 55-75 years). Between September 2017 and September 2018, 3310 admissions were included, among which 2557 (77.3%) were for primary cardiac problems, 337 (10.2%) for postprocedural care, 253 (7.7%) for mixed general and cardiac problems, and 163 (4.9%) for overflow from general medical ICUs. When restricted to the initial 2 months of medical CICU admissions for each site, the primary analysis population included 3049 admissions with a high burden of noncardiovascular comorbidities. The top 2 CICU admission diagnoses were acute coronary syndrome (969 [31.8%]) and heart failure (567 [18.6%]); however, the proportion of acute coronary syndrome was highly variable across centers (15%-57%). The primary indications for CICU care included respiratory insufficiency (814 [26.7%]), shock (643 [21.1%]), unstable arrhythmia (521 [17.1%]), and cardiac arrest (265 [8.7%]). Advanced CICU therapies or monitoring were required for 1776 patients (58.2%), including intravenous vasoactive medications (1105 [36.2%]), invasive hemodynamic monitoring (938 [30.8%]), and mechanical ventilation (652 [21.4%]). The overall CICU mortality rate was 8.3% (95% CI, 7.3%-9.3%). The CICU indications that were associated with the highest mortality rates were cardiac arrest (101 [38.1%]), cardiogenic shock (140 [30.6%]), and the need for renal replacement therapy (51 [34.5%]). Notably, patients admitted solely for postprocedural observation or frequent monitoring had a mortality rate of 0.2% to 0.4%. Conclusions and Relevance: In a contemporary network of tertiary care CICUs, respiratory failure and shock predominated indications for admission and carried a poor prognosis. While patterns of practice varied considerably between centers, a substantial, low-risk population was identified. Multicenter collaborative networks, such as the CCCTN, could be used to help redesign cardiac critical care and to test new therapeutic strategies.
Authors: David A Morrow; James C Fang; Dan J Fintel; Christopher B Granger; Jason N Katz; Frederick G Kushner; Jeffrey T Kuvin; Jose Lopez-Sendon; Dorothea McAreavey; Brahmajee Nallamothu; Robert Lee Page; Joseph E Parrillo; Pamela N Peterson; Chris Winkelman Journal: Circulation Date: 2012-08-14 Impact factor: 29.690
Authors: Carlos L Alviar; P Elliott Miller; Dorothea McAreavey; Jason N Katz; Burton Lee; Brad Moriyama; Jeffrey Soble; Sean van Diepen; Michael A Solomon; David A Morrow Journal: J Am Coll Cardiol Date: 2018-09-25 Impact factor: 24.094
Authors: Emelia J Benjamin; Salim S Virani; Clifton W Callaway; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Stephanie E Chiuve; Mary Cushman; Francesca N Delling; Rajat Deo; Sarah D de Ferranti; Jane F Ferguson; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Pamela L Lutsey; Jason S Mackey; David B Matchar; Kunihiro Matsushita; Michael E Mussolino; Khurram Nasir; Martin O'Flaherty; Latha P Palaniappan; Ambarish Pandey; Dilip K Pandey; Mathew J Reeves; Matthew D Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Uchechukwu K A Sampson; Gary M Satou; Svati H Shah; Nicole L Spartano; David L Tirschwell; Connie W Tsao; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner Journal: Circulation Date: 2018-01-31 Impact factor: 29.690
Authors: Eric Bonnefoy-Cudraz; Hector Bueno; Gianni Casella; Elia De Maria; Donna Fitzsimons; Sigrun Halvorsen; Christian Hassager; Zaza Iakobishvili; Ahmed Magdy; Toomas Marandi; Jorge Mimoso; Alexander Parkhomenko; Susana Price; Richard Rokyta; Francois Roubille; Pranas Serpytis; Avi Shimony; Janina Stepinska; Diana Tint; Elina Trendafilova; Marco Tubaro; Christiaan Vrints; David Walker; Doron Zahger; Endre Zima; Robert Zukermann; Maddalena Lettino Journal: Eur Heart J Acute Cardiovasc Care Date: 2017-08-17
Authors: Shashank S Sinha; Michael W Sjoding; Devraj Sukul; Hallie C Prescott; Theodore J Iwashyna; Hitinder S Gurm; Colin R Cooke; Brahmajee K Nallamothu Journal: Circ Cardiovasc Qual Outcomes Date: 2017-08
Authors: Graham C Wong; Sean van Diepen; Craig Ainsworth; Rakesh C Arora; Jean G Diodati; Mark Liszkowski; Michael Love; Chris Overgaard; Greg Schnell; Jean-Francois Tanguay; George Wells; Michel Le May Journal: Can J Cardiol Date: 2016-11-03 Impact factor: 5.223
Authors: J L Vincent; A de Mendonça; F Cantraine; R Moreno; J Takala; P M Suter; C L Sprung; F Colardyn; S Blecher Journal: Crit Care Med Date: 1998-11 Impact factor: 7.598
Authors: David D Berg; Christopher F Barnett; Benjamin B Kenigsberg; Alexander Papolos; Carlos L Alviar; Vivian M Baird-Zars; Gregory W Barsness; Erin A Bohula; Joseph Brennan; James A Burke; Anthony P Carnicelli; Sunit-Preet Chaudhry; Paul C Cremer; Lori B Daniels; Andrew P DeFilippis; Daniel A Gerber; Christopher B Granger; Steven Hollenberg; James M Horowitz; James D Gladden; Jason N Katz; Ellen C Keeley; Norma Keller; Michael C Kontos; Patrick R Lawler; Venu Menon; Thomas S Metkus; P Elliott Miller; Jose Nativi-Nicolau; L Kristin Newby; Jeong-Gun Park; Nicholas Phreaner; Robert O Roswell; Steven P Schulman; Shashank S Sinha; R Jeffrey Snell; Michael A Solomon; Jeffrey J Teuteberg; Wayne Tymchak; Sean van Diepen; David A Morrow Journal: Circ Heart Fail Date: 2019-11-11 Impact factor: 8.790
Authors: Siddharth M Patel; Jacob C Jentzer; Carlos L Alviar; Vivian M Baird-Zars; Gregory W Barsness; David D Berg; Erin A Bohula; Lori B Daniels; Andrew P DeFilippis; Ellen C Keeley; Michael C Kontos; Patrick R Lawler; P Elliott Miller; Jeong-Gun Park; Robert O Roswell; Michael A Solomon; Sean van Diepen; Jason N Katz; David A Morrow Journal: Eur Heart J Acute Cardiovasc Care Date: 2022-03-16
Authors: Alexander Thomas; Sean van Diepen; Rachel Beekman; Shashank S Sinha; Samuel B Brusca; Carlos L Alviar; Jacob Jentzer; Erin A Bohula; Jason N Katz; Andi Shahu; Christopher Barnett; David A Morrow; Emily J Gilmore; Michael A Solomon; P Elliott Miller Journal: JACC Adv Date: 2022-08-26
Authors: Anubodh S Varshney; David D Berg; Jason N Katz; Vivian M Baird-Zars; Erin A Bohula; Anthony P Carnicelli; Sunit-Preet Chaudhry; Jianping Guo; Patrick R Lawler; Jose Nativi-Nicolau; Shashank S Sinha; Jeffrey J Teuteberg; Sean van Diepen; David A Morrow Journal: JAMA Cardiol Date: 2020-06-01 Impact factor: 14.676
Authors: Behnam N Tehrani; Alexander G Truesdell; Mitchell A Psotka; Carolyn Rosner; Ramesh Singh; Shashank S Sinha; Abdulla A Damluji; Wayne B Batchelor Journal: JACC Heart Fail Date: 2020-11 Impact factor: 12.035
Authors: Matthew C Langston; Keshab Subedi; Carly Fabrizio; Neil J Wimmer; Usman I Choudhry; Luis E Urrutia Journal: Heart Lung Date: 2021-05-30 Impact factor: 3.149
Authors: Shiva Nandiwada; Sunjidatul Islam; Jacob C Jentzer; P Elliott Miller; Christopher B Fordyce; Patrick Lawler; Carlos L Alviar; Louise Y Sun; Douglas C Dover; Renato D Lopes; Padma Kaul; Sean van Diepen Journal: Eur Heart J Acute Cardiovasc Care Date: 2021-10-01
Authors: P Elliott Miller; Alexander Thomas; Thomas J Breen; Fouad Chouairi; Yukiko Kunitomo; Faisal Aslam; Abdulla A Damluji; Nandan S Anavekar; Joseph G Murphy; Sean van Diepen; Gregory W Barsness; Joseph Brennan; Jacob Jentzer Journal: Am J Med Date: 2020-10-28 Impact factor: 4.965